The global progressive fibrosing interstitial lung diseases (PFILD) treatment market is experiencing substantial growth, driven by increasing prevalence, heightened awareness, and advancements in healthcare technology. According to a recent market analysis, the global PFILD treatment market is valued at USD 4742.2 Million in 2023 and is projected to reach USD 8654.1 Million by 2033, expanding …